NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mollie LeoniMed2026-09-2928,802$10.75
$309.56kSell
Kathleen FordCOO2026-09-293,668$10.75
$39.44kSell
Brian T. PowlCCO2026-09-2915,430$10.75
$165.86kSell
Mollie LeoniMed2026-09-2812,448$10.50
$130.67kSell
Teresa Brophy BairCLO2026-09-288,442$10.50
$88.62kSell
Thomas James DoyleSVP2026-09-284,607$10.50
$48.36kSell
Kathleen FordCOO2026-09-286,906$10.50
$72.49kSell
Brian T. PowlCCO2026-09-288,000$10.56
$84.50kSell
Brian T. PowlCCO2026-09-289,020$10.50
$94.68kSell
Francis BurrowsCSci2026-09-2430,000$6.15
$184.50kBuy

1 of 5

KURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital Fund Qualified LP4.96%4,408,097$46.42MInsider
Troy Edward Wilson2.04%1,818,844$19.15MInsider
Pingda Ren0.87%773,982$8.15MInsider
Yi Liu0.84%749,999$7.90MInsider
Argyris Vassiliou0.42%375,000$3.95MInsider
Antonio Gualberto0.38%339,973$3.58MInsider
Heidi Henson0.28%250,000$2.63MInsider
Teresa Brophy Bair0.21%187,002$1.97MInsider
Thomas Malley0.17%149,557$1.57MInsider
Thomas James Doyle0.16%143,428$1.51MInsider

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA0.10%11.09%Net SellingNet Buying
SPTX0.07%74.84%Net Buying
ANRO0.08%16.24%Net BuyingNet Buying
MLTX0.09%22.01%Net SellingNet Selling
ANL0.01%9.10%Net SellingNet Selling

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 0.10% institutional shareholders, 11.09% Kura Oncology insiders, and 88.81% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 4.96% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $47.03M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.